Lombard Odier Asset Management (Switzerland)’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Lombard Odier Asset Management (Switzerland)’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-175,176	Closed	-$24.1M	–	415
2021 Q4	$24.1M	Sell	175,176 -27,835	-14%	-$3.54M	1.54%	26
2021 Q3	$28.2M	Sell	203,011 -67,347	-25%	-$8.41M	1.75%	10
2021 Q2	$26.2M	Buy	+270,358	New	+$21.9M	1.33%	21

Other funds holding BHVN

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Lombard Odier Asset Management (Switzerland)'s BHVN Position: Q1 2022 in Review

Lombard Odier Asset Management (Switzerland) sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q1 2022, closing a stake of 175,176 shares — an estimated $24.1M sold.

Lombard Odier Asset Management (Switzerland) first reported a position in BHVN in Q2 2021 and held it in 3 quarters. The position peaked at $28.2M in Q3 2021. 307 funds tracked by Wall St. Rank hold BHVN as of Q1 2022.

Lombard Odier Asset Management (Switzerland) reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q1 2022 after selling out during the quarter.
Lombard Odier Asset Management (Switzerland) sold 175,176 Biohaven Pharmaceutical Holding Company Ltd. shares in Q1 2022, an estimated $24.1M.
Lombard Odier Asset Management (Switzerland) first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2021 and held it in 3 quarters.
Lombard Odier Asset Management (Switzerland)'s Biohaven Pharmaceutical Holding Company Ltd. position peaked at $28.2M in Q3 2021.
307 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q1 2022.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q1 2022, filed 16 May 2022.